PALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), an innovative media and entertainment company focused on the global ...

LAS VEGAS, NV / ACCESS Newswire / May 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce ...

Rising Demand Spurs US Med-Equip Expansion Across Arizona and the Southwest TUCSON, ARIZONA / ACCESS Newswire / May 1, 2025 / ...

Marks second acquisition in Northeast Ohio; name will change to Saint Therese of Westlake  ST. LOUIS PARK, MN / ACCESS ...

SPOKANE, WA / ACCESS Newswire / May 1, 2025 / Singleton Schreiber is proud to welcome former U.S. Attorney Vanessa Waldref and former Assistant U.S. Attorney Dan Fruchter as partners in the firm's ...

Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again ...

Third-party benefit administrators to gather for discussions on regulatory changes, cost containment strategies, and emerging innovations shaping the future of self-funded healthcare ST. LOUIS, MO / ...

BETHANY, MISSOURI / ACCESS Newswire / May 1, 2025 / Emergency Care Partners (ECP) and its Missouri-based partner physician group, Missouri Physician Partners (MPP), have announced an expansion to ...

Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial ...

Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, today announces that the first patient has been enrolled in the Phase 1 clinical trial of its drug candidate 177Lu ...

Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF) ...

Key appointment to support company in scaling biorepository and stability storage operationsRochdale, UK, 28 April 2025: ...